Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
7.26
Oct 29 • 3:59 PM ET Dollar change+0.01 Percentage change(0.14%)
Aftermarket Close
7.26
Aftermarket • 5:00 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
192.67M
Enterprise Value
101.62M
Income
-24.59M
Sales
354.30M
Book/sh
6.54
Cash/sh
4.03
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
753
IPO
Feb 14, 2014
P/E
-
Forward P/E
-
PEG
-
P/S
0.54
P/B
1.11
P/C
1.80
P/FCF
-
EV/EBITDA
-
EV/Sales
0.29
Quick Ratio
2.34
Current Ratio
2.74
Debt/Eq
0.09
LT Debt/Eq
0.07
Option/Short
Yes / Yes
EPS (ttm)
-0.90
EPS next Y
-0.48
EPS next Q
-0.14
EPS this Y
11.17%
EPS next Y
37.58%
EPS next 5Y
32.01%
EPS past 3/5Y
38.44% -26.38%
Sales past 3/5Y
-2.59% 2.48%
EPS Y/Y TTM
14.61%
Sales Y/Y TTM
3.15%
EPS Q/Q
7.53%
Sales Q/Q
3.04%
Insider Own
3.70%
Insider Trans
-2.16%
Inst Own
73.09%
Inst Trans
0.46%
ROA
-8.23%
ROE
-13.14%
ROIC
-13.12%
Gross Margin
51.66%
Oper. Margin
-8.39%
Profit Margin
-6.94%
SMA20
11.84%
SMA50
24.96%
SMA200
16.67%
Trades
Shs Outstand
26.73M
Shs Float
25.56M
52W High
8.69 -16.46%
52W Low
5.05 43.90%
Volatility
3.32% 4.03%
ATR (14)
0.22
RSI (14)
77.54
Beta
1.58
Rel Volume
0.85
Avg Volume
302.80K
Volume
257,605
Perf Week
3.12%
Perf Month
37.76%
Perf Quarter
12.56%
Perf Half Y
2.11%
Perf YTD
8.04%
Perf Year
-13.67%
Perf 3Y
72.45%
Perf 5Y
-81.69%
Perf 10Y
-86.41%
Prev Close
7.25
Price
7.26
Change %
0.14%
Consensus
Strong Buy
Avg. Price Target
$12.00
Implied Upside
+65.3%
Analysts8incl. previous ratings
Rating Distribution4 Buy · 4 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jun 16, 2025Initiated
RILY logoRB. Riley Securities
Buy$14+92.8%
May 22, 2025Upgrade
NNeedham
Hold → Buy$12+65.3%
Feb 15, 2024Upgrade
WWilliam Blair
Mkt Perform → Outperform
Aug 08, 2023Downgrade
JPM logoJJP Morgan
Overweight → Neutral$15 → $8+10.2%
Jul 14, 2023Downgrade
NNeedham
Buy → Hold
Jan 17, 2023Downgrade
WWilliam Blair
Outperform → Mkt Perform
Dec 09, 2021Upgrade
NNeedham
Hold → Buy$47+547.4%
Nov 02, 2021Upgrade
JPM logoJJP Morgan
Underweight → Neutral$45+519.8%
Aug 05, 2021Downgrade
KEY logoKKeyBanc Capital Markets
Overweight → Sector Weight
Jun 04, 2021Upgrade
WWilliam Blair
Mkt Perform → Outperform
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Kevin P.EVP, Bus Dev, GC & SecSep 01 '26Option Exercise0.0018,136041,643Sep 03 05:01 PM
Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR OffJul 01 '26Sale6.6010,93872,1465,039Jul 06 04:36 PM
JENNIFER YI BOYEROfficerJul 01 '26Proposed Sale6.4510,93870,550Jul 01 04:50 PM
Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR OffMay 29 '26Sale6.5310,77070,31315,977Jun 02 04:30 PM
JENNIFER YI BOYEROfficerMay 29 '26Proposed Sale6.5410,77070,436May 29 04:23 PM
Wright Mary EVP, Chief Accounting OfficerMar 01 '26Option Exercise0.007,506020,284Mar 03 05:00 PM
Yi Boyer Jennifer MEVP Entrprs Enblmnt, Ch HR OffMar 01 '26Option Exercise0.0025,017033,699Mar 03 04:59 PM
Ramade GregoireChief Commercial OfficerMar 01 '26Option Exercise0.0013,005050,251Mar 03 04:58 PM
Smith Kevin P.EVP, Bus Dev, GC & SecMar 01 '26Option Exercise0.0014,005028,283Mar 03 04:57 PM
Bourque Michael J.EVP, CFO & TreasurerMar 01 '26Option Exercise0.0042,0070100,949Mar 03 04:57 PM
Smith Kevin Raymond MerrillCEO and PresidentMar 01 '26Option Exercise0.0058,3460147,973Mar 03 04:56 PM
Ramade GregoireChief Commercial OfficerDec 01 '25Option Exercise0.0031,566050,189Dec 02 04:08 PM
Smith Kevin Raymond MerrillCEO and PresidentDec 01 '25Option Exercise0.0028,3340100,108Dec 02 04:06 PM
Inogen, Inc. is a global medical technology company offering innovative respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Beverly, MA.
PresidentMr. Kevin R. M. Smith
General CounselMr. Kevin P. Smith
Executive VP of Enterprise Enablement & Chief Human Resources OfficerMs. Jennifer Yi Boyer
CFOMr. Jason A. Richardson
Executive VP & COOMr. Andrew P. Reding